Multiple Myeloma: New combination gives 60% response rate in refractor

Velecade + Doxil were the two drugs used in combination to obtain the above results. Of the 23 patients on the study 12 were complete responders. [P] Reference: Agstroel #801, ASCO 39th Meeting

Webmaster

September 08, 2003